Natco Pharma Board Approves ₹1,279.36 Crore Rights Issue
Natco Pharma Ltd · Others (Uncategorized) · 25 Sept 2026, 4:49 pm
Natco Pharma Board Approves ₹1,279.36 Crore Rights Issue Natco Pharma's board approved a Rights Issue to raise up to ₹1,279.36 crore through the issuance of 1,70,58,082 equity shares of face value ₹2 each at ₹750 per share (including a ₹748 premium). The entitlement ratio is set at 2 rights shares for every 21 shares held as of the record date on 1st Oct'26. The issue opens on 12th Oct'26 and closes on 22nd Oct'26, with on-market renunciation from 12th Oct'26 to 16th Oct'26. Outstanding equity shares will expand from 17,91,09,870 to 19,61,67,952 post-issue.
Original exchange filing (PDF)
More announcements from Natco Pharma Ltd
- Intimation of Investor Meet · 17 Nov 2026
- Audio link of Earnings Conference Call Q2FY27 · 14 Nov 2026
- Q2 FY27 Earnings Presentation · 13 Nov 2026
- Un audited Financial Results for the quarter and half year ended 30th September, 2026 · 13 Nov 2026
- 19th November, 2026 is the Record Date for the payment of 2nd Interim Dividend for FY 2026-27 · 13 Nov 2026
- Natco Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026 and declaration of 2nd Interim Dividend for FY 2026-27 · 13 Nov 2026
- Outcome of Board Meeting · 13 Nov 2026
- Intimation of schedule of Concall · 13 Nov 2026
